In vitro evaluation of the disposition of a novel cysteine protease inhibitor

Drug Metabolism and Disposition

Volumn 28, Issue 11, 2000, Pages 1343-1351

  Jacobsen, W ^a   Christians, U ^a   Benet, L Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFURALOL; CYCLOSPORIN; CYSTEINE PROTEINASE INHIBITOR; CYTOCHROME P450 3A4; DEBRISOQUINE 4 HYDROXYLASE; DIMETHYLANILINE MONOOXYGENASE; DRUG METABOLITE; K 11777; METHIONINE; MEVINOLIN; N METHYLPIPERAZINE PHENYLALANYLHOMOPHENYLALANYL VINYLSULFONEPHENYL; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ARTICLE; DRUG DISPOSITION; HUMAN; HUMAN CELL; LIVER MICROSOME METABOLISM; MICHAELIS MENTEN KINETICS; PRIORITY JOURNAL;

CYSTEINE PROTEINASE INHIBITORS; CYTOCHROME P-450 ENZYME SYSTEM; HUMAN; IN VITRO; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; SPECTRUM ANALYSIS, MASS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033791657     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug delivery
2. Cruzipain, the major cysteine protease from the protozoan parasite Trypanosoma cruzi
3. Membrane proteases: Roles in tissue remodeling and tumor invasion
4. Involvement of CYP2D6, CYP3A cytochrome P-450 isozymes in N-dealkylation reactions
5. The cysteine protease cathepsin B in cancer
6. The measurement of difference spectra: Application to the cytochromes of microsomes
7. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease
8. Assessment of cytogenetic damage in chagasic children treated with benznidazole
9. Microsomal enzymes involved in toxicology- Analysis and separation
10. Human cytochrome P450 enzymes
11. Debrisoquine-type polymorphism of drug oxidation: Purification from human liver of a cytochrome P-450 isozyme with high activity for bufuralol hydroxylation
12. Peptidefluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi in vitro
13. The mammalian flavin-containing monooxygenases: Molecular characterization and regulation of expression
14. Comparison of the cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver
15. American Trypanosomiasis (Chagas' disease) - A tropical disease now in the United States
16. Simultaneous on-line analysis of sirolimus (rapamycin) and ciclosporin in blood by liquid chromatography/electrospray mass spectrometry
17. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes. Selective catalysis by FMO3
18. Post-cardiac transplant reactivation of Chagas' disease diagnosed by skin biopsy
19. Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes
20. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature
21. Cardiac involvement is a constant finding in acute Chagas' disease: A clinical, parasitological and histopathological study
22. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors
23. Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes
24. Measurement of protein using bicinchoninic acid
25. Microsomal mixed-function amine oxidase. Oxidation products of piperazine-substituted phenothiazine drugs
26. N-Oxygenation of clozapine by flavin-containing monooxygenase
27. Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for oxidative metabolism of lovastatin in rat and human liver microsomes
28. Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases
29. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor
30. Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats